Effects of rimegepant 75 mg daily on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate in healthy female participants.
Rajinder BhardwajJoseph C StringfellowBeth MorrisRobert S CroopRichard J Bertz
Published in: Headache (2023)
The study identified modest elevations in overall EE and NGMN exposures after multiple doses of rimegepant, but these elevations are unlikely to be clinically relevant in healthy females with migraine.